CompletedNCT01512043Updated May 6, 2014

Breathing Control in Patients With Chronic Obstructive Pulmonary Disease (COPD)

An interventional study of Breathing control in COPD, sponsored by Lovisenberg Diakonale Hospital. Completed at 1 site in Norway. Open to participants aged 30 Years and older. Per ClinicalTrials.gov, last updated 2014-05-06.

Sponsored by Lovisenberg Diakonale Hospital · Not applicable and Interventional

Phase: Not applicable
Study type: Interventional
Enrollment: 150
Allocation: Randomized
Ages: 30 Years and older
Sex: All

Study summary

There is a demand for explorative and comparative studies on various non-pharmaceutical efforts in treating and helping chronic obstructive pulmonary disease patients. This study has been developed in light of this need. The main purpose of the project is to test whether a device guided breathing control system can decreasing the feeling of breathlessness in patients with moderate stage and severe stage of COPD. In addition the study could shed light on whether a reduced feeling of breathlessness can lead to improved physical function, and less experience of other symptoms (I.e., depression, anxiety, sleeping difficulties, fatigue, pain) and provide a better quality of life for patients with COPD.

Conditions studied

COPD

Browse trials for

Keywords

Breathlessness
Symptoms
Quality of life

In context

Lung Diseases, Obstructive

2,592 studies on the registry are indexed under Lung Diseases, Obstructive; 198 are open to participants now.

This study's enrollment of 150 is above the median of 66 across 1,837 interventional studies indexed under Lung Diseases, Obstructive.

Browse Lung Diseases, Obstructive studies →

Lead sponsor

Lovisenberg Diakonale Hospital is the lead sponsor of 24 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

Who can participate

Ages eligible: 30 Years and older
Sexes eligible: All
Accepts healthy volunteers: No

Inclusion criteria

Dyspnoea symptoms in daily life
Spirometry values showing a COPD moderate stage II (FEV1/FVC\<70%, FEV1\<80%) and severity grade at a severe stage III (FEV1/FVC\<70%, FEV1\<50% and FEV1 = 30% of a predicted)
Be able to read, write and speak Norwegian
Be at a stable phase of the disease

Exclusion criteria

Exclusion Criteria:

Changes in pulmonary medication during the last 4 weeks
Diagnosis of cancer
Presently attending a pulmonary rehabilitation course or other similar COPD education courses (due to the fact that these courses often have instructions on breathing control), or having attended similar courses during the last six months
Ongoing exacerbation
Attending other competitive studies
Diagnosis of neuromuscular disease
Diagnosis of dementia
Attending help from a pulmonary physiotherapist

Study design

Phase: Not applicable
Allocation: Randomized
Intervention model: Parallel assignment
Masking: Double (Participant, Investigator)
Enrollment: 150 participants (actual)

Study arms

Experimental
1. Breathing control
Description ...
Behavioral: Breathing control
Active comparator
2. Listening to music
Listening to music without guiding on breathing on the same device as breathing control twice a day for four weeks. Using the device to measure breathing movements.
Behavioral: Breathing control
Sham comparator
3. Silence
Using the device to measure breathing movement twice a day for four weeks. No instruction on breathing control and no music.
Behavioral: Breathing control

Interventions

BehavioralBreathing control
Practice of device guided breathing control twice a day for four weeks.

What researchers measure

Primary outcomes

Breathlessness
Questionnaires
Time frame: 4 months

Secondary outcomes

Depression
Questionnaires
Time frame: 4 months
Pulmonary functional tests
Time frame: 4 months
Anxiety
Questionnaires
Time frame: 4 months
Fatigue
Questionnaire
Time frame: 4 months
Sleeping difficulties
Questionnaires
Time frame: 4 months
Pain
Questionnaire
Time frame: 4 months
6. Min walk test
Time frame: 4 months
Arterial blood gas measures
Time frame: 4 months
Quality of life
Questionnaire
Time frame: 4 months

Study locations

1 site

Lovisenberg Diakonale Hospital
Oslo, 0440, Norway

Updates

Tracking since Sep 25, 2026

No changes since tracking began. The registry record was last updated on May 6, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗

Registry details

Key details

Study ID: NCT01512043
Lead sponsor: Lovisenberg Diakonale Hospital
Collaborators: University of Oslo, Norwegian Foundation for Health and Rehabilitation, University of Bergen
Responsible party: Sponsor
First posted: Jan 19, 2012
Start date: Jul 2011
Primary completion: Sep 2013
Completion: Sep 2013
Last update: May 6, 2014

Study contacts

Astrid K Wahl, Professor

principal investigator · University of Oslo

Oversight

Data monitoring committee: Yes

View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Lung Diseases, Obstructive→

Other studies from this sponsor

Lovisenberg Diakonale Hospital

Start the discussion